L. A. Ruyatkina

Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial

Matthias von Herrath, Stephen C. Bain, Bruce W. Bode et al. · The Lancet Diabetes & Endocrinology · 2021 · 163 citations · Full text

Inflammation, β-Cell Function, Diabetes Management +7

INTERDISCIPLINARY CLINICAL PRACTICE GUIDELINES "MANAGEMENT OF OBESITY AND ITS COMORBIDITIES"

Marina V. Shestakova, G. А. Melnichenko, I. Z. Bondarenko et al. · Obesity and metabolism · 2021 · 118 citations · Full text

Opportunities and options for surrogate assessment of insulin resistance

L. A. Ruyatkina, Dmitry S. Ruyatkin, I. S. Iskhakova · Obesity and metabolism · 2019 · 23 citations · Full text

Metabolic Disorder, Cardiometabolic Risk, Surrogate Assessment +19

Glycemia control and choice of antihyperglycemic therapy in patients with type 2 diabetes mellitus and COVID-19: a consensus decision of the board of experts of the Russian association of endocrinologists

Tatiana Vasil'evna Nikonova, Alexander Yur'evich Mayorov, G. R. Galstyan et al. · Diabetes Mellitus · 2022 · 19 citations · Full text

Metabolic Syndrome, Diabetes Management, Long Covid +14

Multidimensional effects of metformin in patients with type 2 diabetes

L. A. Ruyatkina, D. S. Ruyatkin · Diabetes Mellitus · 2016 · 12 citations · Full text

Obesity, Metabolic Syndrome, Diabetes Management +12